Bepreve Chemical Structure (995f4fe0 D861 4137 8090 A8ffc71c46f4 00)
Bepotastine Besilate Solution/ Drops
Product Images NDC 24208-630
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bepotastine Besilate (NDC 24208-630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton (Image 01)
Bepotastine Besilate Ophthalmic Solution is a sterile solution used for topical ophthalmic use to treat eye allergies. Each mL contains 15mg of bepotastine besilate, which is equivalent to 10.7mg of bepotastine, along with inactive ingredients such as monobasic sodium phosphate dihydrate, sodium chloride, sodium hydroxide to adjust the pH, and water for injection, USP. The solution also contains a preservative called benzalkonium chloride in the amount of 0.005%. This product is manufactured by Bausch & Lomb, Tampa, Florida, under license from Senju Pharmaceutical Co., Ltd., Osaka, Japan. The product is patented under US Patent Numbers 8,784,789 and 8,877,168. The usual dosage of Bepotastine Besilate Ophthalmic Solution is one drop in the affected eye(s) twice a day. It is advised to instruct patients on precautions to avoid contamination. The product should be stored between 15°C to 25°C (59°F to 77°F). The NDC (National Drug Code) is 24208-630-05. Overall, this is a prescription drug used to treat allergic reactions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
